Undervalued Dividend Growth Stock of the Week: Merck (MRK)
It’s set up for a golden era and in many ways, never looked better.
Read Moreby Jason Fieber, Dividends And Income | Dec 23, 2024
It’s set up for a golden era and in many ways, never looked better.
Read Moreby Jason Fieber, Dividends And Income | Dec 16, 2024
With a market-smashing yield, inflation-beating dividend growth, and the potential that shares are 28% undervalued, dividend growth investors in the market for deep value and high yield have a very interesting opportunity on their hands with this one.
Read Moreby Jason Fieber, Dividends And Income | Dec 9, 2024
With a market-smashing yield, more than 25 consecutive years of dividend increases, and the potential that shares are 16% undervalued, value-seeking dividend growth investors willing to take a swing on a beaten-up stock have a fat pitch coming right down the plate here.
Read Moreby Jason Fieber, Dividends And Income | Dec 2, 2024
This could be a unique opportunity to invest in a terrific business at a better-than-fair price.
Read Moreby Jason Fieber, Dividends And Income | Nov 25, 2024
With a market-beating yield, a double-digit long-term dividend growth rate, and the potential that shares are 21% undervalued, this appears to be the cheapest way to play US defense in a world where geopolitical tensions are showing no signs of abating.
Read Moreby Jason Fieber, Dividends And Income | Nov 18, 2024
With a market-beating yield, a double-digit long-term dividend growth rate, and the potential that shares are 12% undervalued, dividend growth investors looking to up their exposure to real estate and/or infrastructure should take a close look at this name after its large drawdown.
Read Moreby Jason Fieber, Dividends And Income | Nov 11, 2024
With a market-smashing yield, inflation-beating dividend growth, and the potential that shares are 26% undervalued, long-term dividend growth investors who like a contrarian, reversion-to-mean play have a prime candidate here.
Read Moreby Jason Fieber, Dividends And Income | Nov 4, 2024
With a market-like yield, double-digit dividend growth, and the potential that shares are 3% undervalued, this could be one of the best ways for long-term dividend growth investors to tap into the the 21st century’s “liquid gold”.’
Read Moreby Jason Fieber, Dividends And Income | Oct 28, 2024
With a market-smashing yield, inflation-beating dividend growth, and the potential that shares are 7% undervalued, long-term dividend growth investors who lean toward yield and income could have a cheap opportunity on their hands with this stock still down heavily from recent highs.
Read Moreby Jason Fieber, Dividends And Income | Oct 21, 2024
With a market-smashing yield, inflation-beating dividend growth and more than 30 consecutive years of dividend increases, income-oriented dividend growth investors still have a chance to pay a fair price for this world-class name.
Read Moreby Jason Fieber, Dividends And Income | Oct 14, 2024
With a market-smashing yield, a double-digit long-term dividend growth rate and the potential that shares are 24% undervalued, dividend growth investors who lean toward yield and value should take a close look at this stock after its 60% fall.
Read Moreby Jason Fieber, Dividends And Income | Oct 7, 2024
With a market-beating yield, nearly 10 consecutive years of dividend increases, and the potential that shares are 13% undervalued, long-term dividend growth investors have a chance to buy an above-average REIT at a below-average valuation.
Read More